nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—PDGFRB—anemia	0.273	0.413	CbGaD
Nilotinib—KIT—anemia	0.195	0.296	CbGaD
Nilotinib—UGT1A1—anemia	0.192	0.291	CbGaD
Nilotinib—Ponatinib—KIT—anemia	0.00169	0.347	CrCbGaD
Nilotinib—Imatinib—PDGFRB—anemia	0.00145	0.299	CrCbGaD
Nilotinib—Imatinib—KIT—anemia	0.00104	0.214	CrCbGaD
Nilotinib—TIE1—hematopoietic system—anemia	0.00091	0.00706	CbGeAlD
Nilotinib—KIT—endothelium—anemia	0.000892	0.00692	CbGeAlD
Nilotinib—CDC42BPB—gonad—anemia	0.000882	0.00684	CbGeAlD
Nilotinib—BLK—blood—anemia	0.00088	0.00682	CbGeAlD
Nilotinib—CSF1R—blood plasma—anemia	0.000872	0.00676	CbGeAlD
Nilotinib—MAPK8—kidney—anemia	0.00086	0.00667	CbGeAlD
Nilotinib—MAPK8—cortex of kidney—anemia	0.000838	0.0065	CbGeAlD
Nilotinib—EPHA4—embryo—anemia	0.00081	0.00628	CbGeAlD
Nilotinib—CDC42BPB—digestive system—anemia	0.000807	0.00626	CbGeAlD
Nilotinib—MAPK8—gonad—anemia	0.000798	0.00619	CbGeAlD
Nilotinib—EPHA6—gonad—anemia	0.000798	0.00619	CbGeAlD
Nilotinib—HCK—hematopoietic system—anemia	0.000795	0.00617	CbGeAlD
Nilotinib—KIT—blood plasma—anemia	0.000792	0.00614	CbGeAlD
Nilotinib—FRK—endocrine gland—anemia	0.000791	0.00613	CbGeAlD
Nilotinib—CYP2C9—urine—anemia	0.000761	0.0059	CbGeAlD
Nilotinib—MAPK14—embryo—anemia	0.000747	0.00579	CbGeAlD
Nilotinib—FGR—embryo—anemia	0.000744	0.00577	CbGeAlD
Nilotinib—MAPK8—lymphoid tissue—anemia	0.000739	0.00573	CbGeAlD
Nilotinib—MAPK8—digestive system—anemia	0.00073	0.00566	CbGeAlD
Nilotinib—CA1—blood plasma—anemia	0.000725	0.00562	CbGeAlD
Nilotinib—FRK—liver—anemia	0.000713	0.00553	CbGeAlD
Nilotinib—MAPK8—blood—anemia	0.000695	0.00539	CbGeAlD
Nilotinib—LYN—lymphoid tissue—anemia	0.000682	0.00529	CbGeAlD
Nilotinib—TEK—embryo—anemia	0.000677	0.00525	CbGeAlD
Nilotinib—MAPK8—bone marrow—anemia	0.000673	0.00522	CbGeAlD
Nilotinib—MAP4K1—lymphoid tissue—anemia	0.000672	0.00521	CbGeAlD
Nilotinib—CDC42BPB—endocrine gland—anemia	0.000667	0.00517	CbGeAlD
Nilotinib—MAPK14—hematopoietic system—anemia	0.000667	0.00517	CbGeAlD
Nilotinib—FGR—hematopoietic system—anemia	0.000664	0.00515	CbGeAlD
Nilotinib—LYN—blood—anemia	0.000642	0.00498	CbGeAlD
Nilotinib—CA7—kidney—anemia	0.000638	0.00495	CbGeAlD
Nilotinib—MAP4K1—blood—anemia	0.000632	0.0049	CbGeAlD
Nilotinib—EPHB4—hematopoietic system—anemia	0.000632	0.0049	CbGeAlD
Nilotinib—EPHA2—hematopoietic system—anemia	0.00062	0.00481	CbGeAlD
Nilotinib—PDGFRA—embryo—anemia	0.000614	0.00476	CbGeAlD
Nilotinib—MAP4K1—bone marrow—anemia	0.000612	0.00474	CbGeAlD
Nilotinib—TEK—hematopoietic system—anemia	0.000605	0.00469	CbGeAlD
Nilotinib—MAPK8—endocrine gland—anemia	0.000603	0.00468	CbGeAlD
Nilotinib—EPHA6—endocrine gland—anemia	0.000603	0.00468	CbGeAlD
Nilotinib—EPHB3—digestive system—anemia	0.000602	0.00467	CbGeAlD
Nilotinib—CDC42BPB—liver—anemia	0.000601	0.00466	CbGeAlD
Nilotinib—EPHB4—nephron tubule—anemia	0.000589	0.00457	CbGeAlD
Nilotinib—CYP3A4—urine—anemia	0.00058	0.0045	CbGeAlD
Nilotinib—EPHA2—nephron tubule—anemia	0.000578	0.00448	CbGeAlD
Nilotinib—BRAF—blood—anemia	0.000578	0.00448	CbGeAlD
Nilotinib—CYP2D6—urine—anemia	0.000571	0.00443	CbGeAlD
Nilotinib—HCK—lymphoid tissue—anemia	0.00056	0.00434	CbGeAlD
Nilotinib—BRAF—bone marrow—anemia	0.000559	0.00434	CbGeAlD
Nilotinib—LYN—endocrine gland—anemia	0.000557	0.00432	CbGeAlD
Nilotinib—HCK—digestive system—anemia	0.000553	0.00429	CbGeAlD
Nilotinib—EPHA4—gonad—anemia	0.00055	0.00426	CbGeAlD
Nilotinib—PDGFRA—hematopoietic system—anemia	0.000548	0.00425	CbGeAlD
Nilotinib—MAPK14—kidney—anemia	0.000546	0.00424	CbGeAlD
Nilotinib—MAPK8—liver—anemia	0.000544	0.00422	CbGeAlD
Nilotinib—CA7—digestive system—anemia	0.000541	0.0042	CbGeAlD
Nilotinib—CSF1R—embryo—anemia	0.00054	0.00419	CbGeAlD
Nilotinib—HCK—blood—anemia	0.000527	0.00409	CbGeAlD
Nilotinib—ABL2—blood—anemia	0.000524	0.00406	CbGeAlD
Nilotinib—UGT1A1—hematopoietic system—anemia	0.000523	0.00405	CbGeAlD
Nilotinib—EPHB4—kidney—anemia	0.000518	0.00402	CbGeAlD
Nilotinib—HCK—bone marrow—anemia	0.00051	0.00395	CbGeAlD
Nilotinib—EPHB4—cortex of kidney—anemia	0.000504	0.00391	CbGeAlD
Nilotinib—LYN—liver—anemia	0.000502	0.00389	CbGeAlD
Nilotinib—TEK—kidney—anemia	0.000496	0.00384	CbGeAlD
Nilotinib—KIT—embryo—anemia	0.000491	0.0038	CbGeAlD
Nilotinib—TEK—cortex of kidney—anemia	0.000483	0.00374	CbGeAlD
Nilotinib—CSF1R—hematopoietic system—anemia	0.000482	0.00374	CbGeAlD
Nilotinib—PDGFRB—embryo—anemia	0.000479	0.00372	CbGeAlD
Nilotinib—EPHA4—blood—anemia	0.000479	0.00371	CbGeAlD
Nilotinib—CA9—digestive system—anemia	0.000475	0.00369	CbGeAlD
Nilotinib—TIE1—liver—anemia	0.000471	0.00366	CbGeAlD
Nilotinib—CA2—blood plasma—anemia	0.00047	0.00364	CbGeAlD
Nilotinib—MAPK14—lymphoid tissue—anemia	0.000469	0.00364	CbGeAlD
Nilotinib—FGR—lymphoid tissue—anemia	0.000467	0.00362	CbGeAlD
Nilotinib—MAPK14—digestive system—anemia	0.000464	0.00359	CbGeAlD
Nilotinib—FGR—digestive system—anemia	0.000462	0.00358	CbGeAlD
Nilotinib—EPHB6—cortex of kidney—anemia	0.000461	0.00358	CbGeAlD
Nilotinib—CA3—bone marrow—anemia	0.000458	0.00355	CbGeAlD
Nilotinib—HCK—endocrine gland—anemia	0.000457	0.00354	CbGeAlD
Nilotinib—BRAF—liver—anemia	0.000452	0.0035	CbGeAlD
Nilotinib—CYP2C8—blood plasma—anemia	0.000447	0.00347	CbGeAlD
Nilotinib—MAPK14—blood—anemia	0.000442	0.00342	CbGeAlD
Nilotinib—FGR—blood—anemia	0.00044	0.00341	CbGeAlD
Nilotinib—LCK—blood—anemia	0.00044	0.00341	CbGeAlD
Nilotinib—EPHB4—digestive system—anemia	0.000439	0.00341	CbGeAlD
Nilotinib—KIT—hematopoietic system—anemia	0.000438	0.0034	CbGeAlD
Nilotinib—EPHA2—lymphoid tissue—anemia	0.000436	0.00338	CbGeAlD
Nilotinib—Imatinib—CYP1A2—anemia	0.000434	0.0893	CrCbGaD
Nilotinib—EPHA2—digestive system—anemia	0.000431	0.00334	CbGeAlD
Nilotinib—UGT1A1—kidney—anemia	0.000428	0.00332	CbGeAlD
Nilotinib—PDGFRB—hematopoietic system—anemia	0.000428	0.00332	CbGeAlD
Nilotinib—MAPK14—bone marrow—anemia	0.000427	0.00331	CbGeAlD
Nilotinib—ABL1—embryo—anemia	0.000427	0.00331	CbGeAlD
Nilotinib—TEK—lymphoid tissue—anemia	0.000426	0.0033	CbGeAlD
Nilotinib—LCK—bone marrow—anemia	0.000426	0.0033	CbGeAlD
Nilotinib—FGR—bone marrow—anemia	0.000426	0.0033	CbGeAlD
Nilotinib—EPHB4—blood—anemia	0.000419	0.00325	CbGeAlD
Nilotinib—PDGFRA—gonad—anemia	0.000417	0.00323	CbGeAlD
Nilotinib—EPHA4—endocrine gland—anemia	0.000415	0.00322	CbGeAlD
Nilotinib—CA12—kidney—anemia	0.000415	0.00321	CbGeAlD
Nilotinib—HCK—liver—anemia	0.000412	0.0032	CbGeAlD
Nilotinib—EPHA2—blood—anemia	0.000411	0.00318	CbGeAlD
Nilotinib—CA3—endocrine gland—anemia	0.00041	0.00318	CbGeAlD
Nilotinib—ABL2—liver—anemia	0.00041	0.00318	CbGeAlD
Nilotinib—KIT—nephron tubule—anemia	0.000409	0.00317	CbGeAlD
Nilotinib—EPHB4—bone marrow—anemia	0.000405	0.00314	CbGeAlD
Nilotinib—CYP2B6—blood plasma—anemia	0.000401	0.00311	CbGeAlD
Nilotinib—TEK—blood—anemia	0.000401	0.00311	CbGeAlD
Nilotinib—CA1—hematopoietic system—anemia	0.000401	0.00311	CbGeAlD
Nilotinib—CYP2C9—blood plasma—anemia	0.000397	0.00308	CbGeAlD
Nilotinib—MAP2K5—cortex of kidney—anemia	0.000395	0.00306	CbGeAlD
Nilotinib—CA9—endocrine gland—anemia	0.000393	0.00305	CbGeAlD
Nilotinib—PDGFRA—lymphoid tissue—anemia	0.000386	0.00299	CbGeAlD
Nilotinib—MAPK14—endocrine gland—anemia	0.000383	0.00297	CbGeAlD
Nilotinib—EPHB6—blood—anemia	0.000383	0.00297	CbGeAlD
Nilotinib—FGR—endocrine gland—anemia	0.000381	0.00296	CbGeAlD
Nilotinib—ABL1—hematopoietic system—anemia	0.000381	0.00296	CbGeAlD
Nilotinib—PDGFRA—digestive system—anemia	0.000381	0.00295	CbGeAlD
Nilotinib—CA3—liver—anemia	0.00037	0.00287	CbGeAlD
Nilotinib—CSF1R—gonad—anemia	0.000367	0.00284	CbGeAlD
Nilotinib—UGT1A1—digestive system—anemia	0.000363	0.00282	CbGeAlD
Nilotinib—EPHB4—endocrine gland—anemia	0.000363	0.00282	CbGeAlD
Nilotinib—PDGFRA—blood—anemia	0.000363	0.00281	CbGeAlD
Nilotinib—KIT—kidney—anemia	0.000359	0.00278	CbGeAlD
Nilotinib—EPHA2—endocrine gland—anemia	0.000356	0.00276	CbGeAlD
Nilotinib—ABL1—nephron tubule—anemia	0.000356	0.00276	CbGeAlD
Nilotinib—CA12—digestive system—anemia	0.000352	0.00273	CbGeAlD
Nilotinib—PDGFRB—kidney—anemia	0.000351	0.00272	CbGeAlD
Nilotinib—KIT—cortex of kidney—anemia	0.00035	0.00271	CbGeAlD
Nilotinib—TEK—endocrine gland—anemia	0.000348	0.00269	CbGeAlD
Nilotinib—UGT1A1—blood—anemia	0.000346	0.00268	CbGeAlD
Nilotinib—MAPK14—liver—anemia	0.000345	0.00268	CbGeAlD
Nilotinib—FGR—liver—anemia	0.000344	0.00267	CbGeAlD
Nilotinib—LCK—liver—anemia	0.000344	0.00267	CbGeAlD
Nilotinib—PDGFRB—cortex of kidney—anemia	0.000342	0.00265	CbGeAlD
Nilotinib—CSF1R—lymphoid tissue—anemia	0.00034	0.00263	CbGeAlD
Nilotinib—CA14—liver—anemia	0.000336	0.0026	CbGeAlD
Nilotinib—CSF1R—digestive system—anemia	0.000335	0.0026	CbGeAlD
Nilotinib—KIT—gonad—anemia	0.000333	0.00258	CbGeAlD
Nilotinib—CA1—kidney—anemia	0.000328	0.00255	CbGeAlD
Nilotinib—MAP2K5—blood—anemia	0.000327	0.00254	CbGeAlD
Nilotinib—EPHB4—liver—anemia	0.000327	0.00254	CbGeAlD
Nilotinib—PDGFRB—gonad—anemia	0.000325	0.00252	CbGeAlD
Nilotinib—EPHA2—liver—anemia	0.000321	0.00249	CbGeAlD
Nilotinib—CSF1R—blood—anemia	0.00032	0.00248	CbGeAlD
Nilotinib—PDGFRA—endocrine gland—anemia	0.000315	0.00244	CbGeAlD
Nilotinib—TEK—liver—anemia	0.000313	0.00243	CbGeAlD
Nilotinib—ABL1—kidney—anemia	0.000313	0.00242	CbGeAlD
Nilotinib—CSF1R—bone marrow—anemia	0.000309	0.0024	CbGeAlD
Nilotinib—KIT—lymphoid tissue—anemia	0.000308	0.00239	CbGeAlD
Nilotinib—KIT—digestive system—anemia	0.000305	0.00236	CbGeAlD
Nilotinib—ABL1—cortex of kidney—anemia	0.000304	0.00236	CbGeAlD
Nilotinib—CYP3A4—blood plasma—anemia	0.000303	0.00235	CbGeAlD
Nilotinib—PDGFRB—lymphoid tissue—anemia	0.000301	0.00234	CbGeAlD
Nilotinib—UGT1A1—endocrine gland—anemia	0.0003	0.00233	CbGeAlD
Nilotinib—CYP2D6—blood plasma—anemia	0.000298	0.00231	CbGeAlD
Nilotinib—PDGFRB—digestive system—anemia	0.000298	0.00231	CbGeAlD
Nilotinib—CA4—nephron tubule—anemia	0.000292	0.00226	CbGeAlD
Nilotinib—CA2—embryo—anemia	0.000291	0.00226	CbGeAlD
Nilotinib—CA12—endocrine gland—anemia	0.000291	0.00225	CbGeAlD
Nilotinib—KIT—blood—anemia	0.00029	0.00225	CbGeAlD
Nilotinib—ABL1—gonad—anemia	0.00029	0.00225	CbGeAlD
Nilotinib—MAP2K5—endocrine gland—anemia	0.000284	0.0022	CbGeAlD
Nilotinib—PDGFRA—liver—anemia	0.000284	0.0022	CbGeAlD
Nilotinib—PDGFRB—blood—anemia	0.000283	0.0022	CbGeAlD
Nilotinib—CA1—lymphoid tissue—anemia	0.000282	0.00219	CbGeAlD
Nilotinib—KIT—bone marrow—anemia	0.000281	0.00218	CbGeAlD
Nilotinib—CA1—digestive system—anemia	0.000279	0.00216	CbGeAlD
Nilotinib—CSF1R—endocrine gland—anemia	0.000277	0.00215	CbGeAlD
Nilotinib—PDGFRB—bone marrow—anemia	0.000274	0.00213	CbGeAlD
Nilotinib—UGT1A1—liver—anemia	0.000271	0.0021	CbGeAlD
Nilotinib—ABL1—lymphoid tissue—anemia	0.000268	0.00208	CbGeAlD
Nilotinib—CA1—blood—anemia	0.000265	0.00206	CbGeAlD
Nilotinib—ABL1—digestive system—anemia	0.000265	0.00206	CbGeAlD
Nilotinib—CA2—hematopoietic system—anemia	0.00026	0.00201	CbGeAlD
Nilotinib—CA1—bone marrow—anemia	0.000257	0.00199	CbGeAlD
Nilotinib—CA4—kidney—anemia	0.000257	0.00199	CbGeAlD
Nilotinib—MAP2K5—liver—anemia	0.000256	0.00199	CbGeAlD
Nilotinib—ABL1—blood—anemia	0.000253	0.00196	CbGeAlD
Nilotinib—KIT—endocrine gland—anemia	0.000252	0.00195	CbGeAlD
Nilotinib—Imatinib—ALB—anemia	0.000251	0.0516	CrCbGaD
Nilotinib—CA4—cortex of kidney—anemia	0.00025	0.00194	CbGeAlD
Nilotinib—CSF1R—liver—anemia	0.00025	0.00194	CbGeAlD
Nilotinib—CYP2C8—hematopoietic system—anemia	0.000247	0.00192	CbGeAlD
Nilotinib—PDGFRB—endocrine gland—anemia	0.000246	0.00191	CbGeAlD
Nilotinib—ABL1—bone marrow—anemia	0.000244	0.0019	CbGeAlD
Nilotinib—CA2—nephron tubule—anemia	0.000242	0.00188	CbGeAlD
Nilotinib—CA1—endocrine gland—anemia	0.00023	0.00178	CbGeAlD
Nilotinib—KIT—liver—anemia	0.000227	0.00176	CbGeAlD
Nilotinib—ABCG2—nephron tubule—anemia	0.000224	0.00174	CbGeAlD
Nilotinib—CYP2B6—hematopoietic system—anemia	0.000222	0.00172	CbGeAlD
Nilotinib—PDGFRB—liver—anemia	0.000222	0.00172	CbGeAlD
Nilotinib—CYP2C9—hematopoietic system—anemia	0.00022	0.0017	CbGeAlD
Nilotinib—ABL1—endocrine gland—anemia	0.000219	0.0017	CbGeAlD
Nilotinib—CA4—digestive system—anemia	0.000218	0.00169	CbGeAlD
Nilotinib—ABCB1—blood plasma—anemia	0.000214	0.00166	CbGeAlD
Nilotinib—CA2—kidney—anemia	0.000213	0.00165	CbGeAlD
Nilotinib—CA1—liver—anemia	0.000208	0.00161	CbGeAlD
Nilotinib—CA4—blood—anemia	0.000207	0.00161	CbGeAlD
Nilotinib—CA2—cortex of kidney—anemia	0.000207	0.00161	CbGeAlD
Nilotinib—CYP2B6—nephron tubule—anemia	0.000207	0.0016	CbGeAlD
Nilotinib—CYP2C8—kidney—anemia	0.000203	0.00157	CbGeAlD
Nilotinib—CA4—bone marrow—anemia	0.000201	0.00156	CbGeAlD
Nilotinib—ABL1—liver—anemia	0.000198	0.00153	CbGeAlD
Nilotinib—CA2—lymphoid tissue—anemia	0.000183	0.00142	CbGeAlD
Nilotinib—CYP2B6—kidney—anemia	0.000182	0.00141	CbGeAlD
Nilotinib—CA2—digestive system—anemia	0.000181	0.0014	CbGeAlD
Nilotinib—CA4—endocrine gland—anemia	0.00018	0.0014	CbGeAlD
Nilotinib—CA2—blood—anemia	0.000172	0.00133	CbGeAlD
Nilotinib—CYP2B6—gonad—anemia	0.000169	0.00131	CbGeAlD
Nilotinib—CYP3A4—hematopoietic system—anemia	0.000168	0.0013	CbGeAlD
Nilotinib—CA2—bone marrow—anemia	0.000166	0.00129	CbGeAlD
Nilotinib—CYP2D6—hematopoietic system—anemia	0.000165	0.00128	CbGeAlD
Nilotinib—CYP2C8—blood—anemia	0.000164	0.00127	CbGeAlD
Nilotinib—ABCG2—blood—anemia	0.000159	0.00124	CbGeAlD
Nilotinib—CYP2B6—lymphoid tissue—anemia	0.000156	0.00121	CbGeAlD
Nilotinib—CYP2B6—digestive system—anemia	0.000154	0.0012	CbGeAlD
Nilotinib—ABCG2—bone marrow—anemia	0.000154	0.0012	CbGeAlD
Nilotinib—CYP2C9—digestive system—anemia	0.000153	0.00118	CbGeAlD
Nilotinib—CA2—endocrine gland—anemia	0.000149	0.00116	CbGeAlD
Nilotinib—CYP2B6—blood—anemia	0.000147	0.00114	CbGeAlD
Nilotinib—CYP2C9—blood—anemia	0.000146	0.00113	CbGeAlD
Nilotinib—CYP2C8—endocrine gland—anemia	0.000142	0.0011	CbGeAlD
Nilotinib—CYP3A4—kidney—anemia	0.000137	0.00106	CbGeAlD
Nilotinib—CYP2D6—kidney—anemia	0.000135	0.00105	CbGeAlD
Nilotinib—CA2—liver—anemia	0.000135	0.00104	CbGeAlD
Nilotinib—ABCB1—embryo—anemia	0.000133	0.00103	CbGeAlD
Nilotinib—CYP2C8—liver—anemia	0.000128	0.000993	CbGeAlD
Nilotinib—CYP2B6—endocrine gland—anemia	0.000127	0.000988	CbGeAlD
Nilotinib—CYP2C9—endocrine gland—anemia	0.000126	0.000979	CbGeAlD
Nilotinib—ABCG2—liver—anemia	0.000125	0.000966	CbGeAlD
Nilotinib—ABCB1—hematopoietic system—anemia	0.000119	0.000919	CbGeAlD
Nilotinib—CYP3A4—digestive system—anemia	0.000116	0.000903	CbGeAlD
Nilotinib—CYP2B6—liver—anemia	0.000115	0.000891	CbGeAlD
Nilotinib—CYP2D6—digestive system—anemia	0.000115	0.000889	CbGeAlD
Nilotinib—CYP2C9—liver—anemia	0.000114	0.000882	CbGeAlD
Nilotinib—CYP3A4—blood—anemia	0.000111	0.00086	CbGeAlD
Nilotinib—ABCB1—nephron tubule—anemia	0.000111	0.000857	CbGeAlD
Nilotinib—CYP2D6—blood—anemia	0.000109	0.000847	CbGeAlD
Nilotinib—ABCB1—kidney—anemia	9.72e-05	0.000754	CbGeAlD
Nilotinib—CYP3A4—endocrine gland—anemia	9.63e-05	0.000746	CbGeAlD
Nilotinib—CYP2D6—endocrine gland—anemia	9.47e-05	0.000734	CbGeAlD
Nilotinib—ABCB1—cortex of kidney—anemia	9.47e-05	0.000734	CbGeAlD
Nilotinib—ABCB1—gonad—anemia	9.02e-05	0.000699	CbGeAlD
Nilotinib—CYP3A4—liver—anemia	8.68e-05	0.000673	CbGeAlD
Nilotinib—CYP2D6—liver—anemia	8.54e-05	0.000662	CbGeAlD
Nilotinib—ABCB1—lymphoid tissue—anemia	8.35e-05	0.000647	CbGeAlD
Nilotinib—ABCB1—digestive system—anemia	8.25e-05	0.000639	CbGeAlD
Nilotinib—ABCB1—blood—anemia	7.86e-05	0.000609	CbGeAlD
Nilotinib—ABCB1—bone marrow—anemia	7.6e-05	0.000589	CbGeAlD
Nilotinib—ABCB1—endocrine gland—anemia	6.81e-05	0.000528	CbGeAlD
Nilotinib—ABCB1—liver—anemia	6.14e-05	0.000476	CbGeAlD
Nilotinib—CYP3A4—Metabolism—NDUFA2—anemia	3.17e-06	1.54e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MTHFR—anemia	3.16e-06	1.53e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CSF2—anemia	3.16e-06	1.53e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—KIT—anemia	3.15e-06	1.53e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TPI1—anemia	3.13e-06	1.52e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PRL—anemia	3.12e-06	1.52e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—UGT1A1—anemia	3.12e-06	1.52e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—KIT—anemia	3.12e-06	1.52e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT2—anemia	3.12e-06	1.52e-05	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—IL6—anemia	3.12e-06	1.52e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PDGFRB—anemia	3.11e-06	1.51e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL1B—anemia	3.1e-06	1.51e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—CD4—anemia	3.1e-06	1.51e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TPI1—anemia	3.1e-06	1.51e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—JAK2—anemia	3.1e-06	1.51e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL2—anemia	3.09e-06	1.5e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—AGT—anemia	3.04e-06	1.48e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GSTM1—anemia	3.03e-06	1.47e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—JAK2—anemia	3.03e-06	1.47e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HBA1—anemia	3.03e-06	1.47e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—JAK2—anemia	3.02e-06	1.47e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—KIT—anemia	3.01e-06	1.46e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—AGT—anemia	3e-06	1.46e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOB—anemia	3e-06	1.46e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CSF2—anemia	2.99e-06	1.45e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOB—anemia	2.97e-06	1.44e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—F2—anemia	2.97e-06	1.44e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IFNG—anemia	2.97e-06	1.44e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—JAK2—anemia	2.96e-06	1.44e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—A2M—anemia	2.96e-06	1.44e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTT1—anemia	2.95e-06	1.44e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—IL6—anemia	2.95e-06	1.43e-05	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—IL6—anemia	2.95e-06	1.43e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—JAK2—anemia	2.95e-06	1.43e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PDGFRB—anemia	2.95e-06	1.43e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—UGT1A1—anemia	2.94e-06	1.43e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL1B—anemia	2.94e-06	1.43e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD4—anemia	2.94e-06	1.43e-05	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—IL6—anemia	2.94e-06	1.43e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL2—anemia	2.93e-06	1.42e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GCLC—anemia	2.92e-06	1.42e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—UGT1A1—anemia	2.92e-06	1.42e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IFNG—anemia	2.9e-06	1.41e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SEC24B—anemia	2.9e-06	1.41e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NQO1—anemia	2.9e-06	1.41e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP1A2—anemia	2.9e-06	1.41e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IFNG—anemia	2.89e-06	1.4e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—anemia	2.89e-06	1.4e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—C3—anemia	2.88e-06	1.4e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TERT—anemia	2.87e-06	1.4e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALDOA—anemia	2.87e-06	1.39e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD4—anemia	2.87e-06	1.39e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—KITLG—anemia	2.85e-06	1.38e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GPI—anemia	2.83e-06	1.37e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—DHFR—anemia	2.83e-06	1.37e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—C3—anemia	2.82e-06	1.37e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TERT—anemia	2.81e-06	1.37e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—F2—anemia	2.81e-06	1.37e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—JAK2—anemia	2.81e-06	1.36e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD4—anemia	2.81e-06	1.36e-05	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—IL6—anemia	2.8e-06	1.36e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD4—anemia	2.79e-06	1.36e-05	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL6—anemia	2.79e-06	1.36e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—JAK2—anemia	2.79e-06	1.36e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—A2M—anemia	2.79e-06	1.35e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL2—anemia	2.78e-06	1.35e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—KIT—anemia	2.78e-06	1.35e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IGF2—anemia	2.77e-06	1.35e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—A2M—anemia	2.76e-06	1.34e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LPIN2—anemia	2.76e-06	1.34e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IFNG—anemia	2.75e-06	1.34e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—AGT—anemia	2.74e-06	1.33e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—anemia	2.72e-06	1.32e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALDOA—anemia	2.7e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HBB—anemia	2.7e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ACSL4—anemia	2.7e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT1—anemia	2.69e-06	1.31e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—KIT—anemia	2.69e-06	1.31e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—AGT—anemia	2.68e-06	1.3e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MTHFR—anemia	2.68e-06	1.3e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALDOA—anemia	2.68e-06	1.3e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—C3—anemia	2.68e-06	1.3e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TERT—anemia	2.67e-06	1.3e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—IL6—anemia	2.66e-06	1.29e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD4—anemia	2.66e-06	1.29e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1B—anemia	2.65e-06	1.29e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD4—anemia	2.65e-06	1.29e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL2—anemia	2.64e-06	1.29e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT2—anemia	2.64e-06	1.28e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HBA1—anemia	2.64e-06	1.28e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL2—anemia	2.64e-06	1.28e-05	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—IL6—anemia	2.6e-06	1.27e-05	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—IL6—anemia	2.59e-06	1.26e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1B—anemia	2.59e-06	1.26e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CSF2—anemia	2.59e-06	1.26e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PGK1—anemia	2.59e-06	1.26e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—UMPS—anemia	2.59e-06	1.26e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL2—anemia	2.58e-06	1.25e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1B—anemia	2.58e-06	1.25e-05	CbGpPWpGaD
Nilotinib—HCK—Disease—IL6—anemia	2.58e-06	1.25e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTT1—anemia	2.57e-06	1.25e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL2—anemia	2.57e-06	1.25e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—AGT—anemia	2.55e-06	1.24e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PDGFRB—anemia	2.55e-06	1.24e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GCLC—anemia	2.54e-06	1.24e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—AGT—anemia	2.54e-06	1.24e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—JAK2—anemia	2.54e-06	1.23e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—BRIP1—anemia	2.54e-06	1.23e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—F2—anemia	2.53e-06	1.23e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL6—anemia	2.53e-06	1.23e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL6—anemia	2.53e-06	1.23e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL6—anemia	2.52e-06	1.22e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—JAK2—anemia	2.52e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CUBN—anemia	2.49e-06	1.21e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSR—anemia	2.49e-06	1.21e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HBA1—anemia	2.49e-06	1.21e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—F2—anemia	2.48e-06	1.2e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—IL6—anemia	2.47e-06	1.2e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HBA1—anemia	2.46e-06	1.2e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DHFR—anemia	2.46e-06	1.2e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—anemia	2.46e-06	1.19e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NQO1—anemia	2.46e-06	1.19e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP1A2—anemia	2.46e-06	1.19e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL2—anemia	2.45e-06	1.19e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTT1—anemia	2.43e-06	1.18e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—JAK2—anemia	2.43e-06	1.18e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—KIT—anemia	2.42e-06	1.18e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TCN2—anemia	2.41e-06	1.17e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PKLR—anemia	2.41e-06	1.17e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTT1—anemia	2.4e-06	1.17e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GCLC—anemia	2.4e-06	1.17e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—HMOX1—anemia	2.39e-06	1.16e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFNG—anemia	2.38e-06	1.16e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GCLC—anemia	2.38e-06	1.16e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—KIT—anemia	2.37e-06	1.15e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—F2—anemia	2.35e-06	1.14e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALAS1—anemia	2.33e-06	1.13e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DHFR—anemia	2.32e-06	1.13e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—C3—anemia	2.31e-06	1.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TERT—anemia	2.31e-06	1.12e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ALB—anemia	2.3e-06	1.12e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT2—anemia	2.3e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DHFR—anemia	2.3e-06	1.12e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—anemia	2.3e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADA—anemia	2.29e-06	1.12e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—JAK2—anemia	2.29e-06	1.11e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT1—anemia	2.28e-06	1.11e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ALB—anemia	2.26e-06	1.1e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—KIT—anemia	2.25e-06	1.09e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—JAK2—anemia	2.24e-06	1.09e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTM1—anemia	2.22e-06	1.08e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL2—anemia	2.22e-06	1.08e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—anemia	2.22e-06	1.08e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SEC23A—anemia	2.2e-06	1.07e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AGT—anemia	2.2e-06	1.07e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL2—anemia	2.2e-06	1.07e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—JAK2—anemia	2.17e-06	1.05e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT2—anemia	2.17e-06	1.05e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT2—anemia	2.15e-06	1.04e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—G6PD—anemia	2.14e-06	1.04e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NQO1—anemia	2.14e-06	1.04e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP1A2—anemia	2.14e-06	1.04e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—anemia	2.13e-06	1.04e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—anemia	2.12e-06	1.03e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—anemia	2.12e-06	1.03e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL2—anemia	2.12e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TPI1—anemia	2.05e-06	9.94e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—F2—anemia	2.03e-06	9.87e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HMOX1—anemia	2.02e-06	9.82e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NQO1—anemia	2.02e-06	9.8e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP1A2—anemia	2.02e-06	9.8e-06	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—anemia	2.02e-06	9.79e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL2—anemia	2e-06	9.71e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP1A2—anemia	2e-06	9.71e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NQO1—anemia	2e-06	9.71e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT1—anemia	1.99e-06	9.65e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—anemia	1.96e-06	9.55e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOB—anemia	1.96e-06	9.53e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ALB—anemia	1.95e-06	9.5e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—JAK2—anemia	1.95e-06	9.5e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—KIT—anemia	1.94e-06	9.45e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—UGT1A1—anemia	1.92e-06	9.34e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—JAK2—anemia	1.91e-06	9.3e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL2—anemia	1.89e-06	9.19e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTM1—anemia	1.88e-06	9.15e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT1—anemia	1.87e-06	9.1e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—AGT—anemia	1.87e-06	9.07e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT1—anemia	1.86e-06	9.02e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—anemia	1.84e-06	8.96e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—A2M—anemia	1.82e-06	8.86e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—anemia	1.82e-06	8.83e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—JAK2—anemia	1.81e-06	8.81e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALDOA—anemia	1.77e-06	8.58e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HMOX1—anemia	1.76e-06	8.55e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—anemia	1.72e-06	8.36e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL2—anemia	1.7e-06	8.28e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—anemia	1.68e-06	8.15e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL2—anemia	1.67e-06	8.11e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—anemia	1.66e-06	8.08e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HMOX1—anemia	1.66e-06	8.06e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HMOX1—anemia	1.64e-06	7.99e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTM1—anemia	1.64e-06	7.97e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—anemia	1.64e-06	7.95e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HBA1—anemia	1.62e-06	7.9e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—anemia	1.59e-06	7.72e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTT1—anemia	1.59e-06	7.71e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL2—anemia	1.58e-06	7.69e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—AGT—anemia	1.58e-06	7.68e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—JAK2—anemia	1.57e-06	7.62e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCLC—anemia	1.57e-06	7.62e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—anemia	1.55e-06	7.55e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—anemia	1.55e-06	7.53e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—anemia	1.55e-06	7.51e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—anemia	1.53e-06	7.44e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—anemia	1.52e-06	7.37e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DHFR—anemia	1.52e-06	7.37e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—anemia	1.51e-06	7.34e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—anemia	1.45e-06	7.04e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—anemia	1.44e-06	6.99e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALB—anemia	1.43e-06	6.96e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—anemia	1.43e-06	6.95e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT2—anemia	1.42e-06	6.89e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—AGT—anemia	1.38e-06	6.69e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL2—anemia	1.37e-06	6.65e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—anemia	1.37e-06	6.64e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—anemia	1.35e-06	6.58e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NQO1—anemia	1.32e-06	6.4e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP1A2—anemia	1.32e-06	6.4e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—anemia	1.3e-06	6.33e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—AGT—anemia	1.3e-06	6.3e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—anemia	1.29e-06	6.27e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—AGT—anemia	1.29e-06	6.25e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—anemia	1.24e-06	6.04e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT1—anemia	1.22e-06	5.95e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALB—anemia	1.21e-06	5.89e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—anemia	1.17e-06	5.71e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—anemia	1.15e-06	5.58e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—anemia	1.11e-06	5.4e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMOX1—anemia	1.08e-06	5.27e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALB—anemia	1.06e-06	5.13e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—anemia	1.01e-06	4.91e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—anemia	1e-06	4.87e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALB—anemia	9.96e-07	4.84e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALB—anemia	9.87e-07	4.8e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—anemia	9.81e-07	4.77e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—anemia	9.3e-07	4.52e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—anemia	8.93e-07	4.34e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AGT—anemia	8.48e-07	4.12e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—anemia	8.04e-07	3.91e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALB—anemia	6.51e-07	3.16e-06	CbGpPWpGaD
